ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2018

Cabozantinib, a New Standard of Care for Patients With Advanced Renal Cell Carcinoma and Bone Metastases? Subgroup Analysis of the METEOR Trial.

Bernard Escudier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.